Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations
Journal of Pathology Jun 01, 2019
Khani F, et al. - Because intraductal carcinoma of the prostate (IDC-P) most often seems to be related to high-grade invasive prostate carcinoma (PCa), where it is believed to be a retrograde spread, however, IDC-P rarely occurs as an isolated finding in radical prostatectomy or concurrent low-grade (Grade Group 1) invasive carcinoma, investigators hypothesized that in these unusual cases isolated IDC-P (iIDC-P) may represent a distinct in situ lesion and molecularly profiled 15 cases. Findings revealed that iIDC-P is enriched with potentially targetable oncogenic driver mutations in MAPK/PI3K genes despite a copy number alteration profile similar to conventional PCa. Based on the status of PTEN and ERG, iIDC-P is unlikely to be a precursor to the associated low-grade invasive PCa, but is an unclear clinical significance molecularly unique in situ tumor.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries